France's Covid-19 vaccine woes continue as more regions SUSPEND first doses of Pfizer jab
Two more local public health agencies in France are suspending people's appointments for receiving their first doses of the Covid-19 vaccine made by Pfizer-BioNTech, due to supply shortages.
The eastern Bourgogne-Franche-Comte region and the Île-de-France area surrounding Paris both said on Thursday that they would be axing Covid immunization appointments.
The Parisian ARS health agency said injections of first doses will stop there from February 2 and hospitals won't receive deliveries for the time being, although already-arranged second-dose appointments will still go ahead.
A spokesperson for ARS Bourgogne-Franche-Comte said that some bookings in February would be "postponed for a few days or weeks," but that "no appointment will be canceled."
The ARS health agency for the northern Hauts-de-France region said earlier this week that all of its first-dose appointments until February 2 would be rescheduled for the first week of March.
Officials said the move, prompted by Pfizer supply shortages, would allow those who have already been injected to get their second dose, adding that appointments from February 3 to 15 would be honored.
On Wednesday, the Madrid region of Spain stopped new Covid-19 vaccinations, as the capital's deputy regional president said the "pace of deliveries was interrupted."
US pharmaceutical giant Pfizer is facing pressure from several countries to make up the shortfall of deliveries of the vaccine it produces with German firm BioNTech.
This week, Italy's State Attorney General's Office sent Pfizer a formal notice to "comply with its contractual obligations relating to its failure to deliver vaccine doses."
The company announced earlier this month that there would be shortages to several European nations and Canada, as it upped production capacity for the vaccine at its plant in Belgium.
Meanwhile, Switzerland's health ministry said on Thursday it has been told by drugmaker Moderna that deliveries of its Covid-19 vaccine will be delayed, meaning the country may now not hit its target of one million doses in February.
There is also an ongoing row between Europe's other vaccine heavyweight, AstraZeneca, and the EU, after the bloc accused the company of reneging on its delivery promises when informed by the pharma firm of delays to scheduled deliveries.
The Parisian ARS health agency said injections of first doses will stop there from February 2 and hospitals won't receive deliveries for the time being, although already-arranged second-dose appointments will still go ahead.
A spokesperson for ARS Bourgogne-Franche-Comte said that some bookings in February would be "postponed for a few days or weeks," but that "no appointment will be canceled."
The ARS health agency for the northern Hauts-de-France region said earlier this week that all of its first-dose appointments until February 2 would be rescheduled for the first week of March.
Officials said the move, prompted by Pfizer supply shortages, would allow those who have already been injected to get their second dose, adding that appointments from February 3 to 15 would be honored.
On Wednesday, the Madrid region of Spain stopped new Covid-19 vaccinations, as the capital's deputy regional president said the "pace of deliveries was interrupted."
US pharmaceutical giant Pfizer is facing pressure from several countries to make up the shortfall of deliveries of the vaccine it produces with German firm BioNTech.
This week, Italy's State Attorney General's Office sent Pfizer a formal notice to "comply with its contractual obligations relating to its failure to deliver vaccine doses."
The company announced earlier this month that there would be shortages to several European nations and Canada, as it upped production capacity for the vaccine at its plant in Belgium.
Meanwhile, Switzerland's health ministry said on Thursday it has been told by drugmaker Moderna that deliveries of its Covid-19 vaccine will be delayed, meaning the country may now not hit its target of one million doses in February.
There is also an ongoing row between Europe's other vaccine heavyweight, AstraZeneca, and the EU, after the bloc accused the company of reneging on its delivery promises when informed by the pharma firm of delays to scheduled deliveries.
AI Disclaimer: An advanced artificial intelligence (AI) system generated the content of this page on its own. This innovative technology conducts extensive research from a variety of reliable sources, performs rigorous fact-checking and verification, cleans up and balances biased or manipulated content, and presents a minimal factual summary that is just enough yet essential for you to function as an informed and educated citizen. Please keep in mind, however, that this system is an evolving technology, and as a result, the article may contain accidental inaccuracies or errors. We urge you to help us improve our site by reporting any inaccuracies you find using the "Contact Us" link at the bottom of this page. Your helpful feedback helps us improve our system and deliver more precise content. When you find an article of interest here, please look for the full and extensive coverage of this topic in traditional news sources, as they are written by professional journalists that we try to support, not replace. We appreciate your understanding and assistance.
